Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Trends in Plant Science|April 15, 2015
Fatal attraction: the intuitive appeal of GMO oppositionStefaan Blancke, Frank Van Breusegem, Geert De Jaeger, et al.
Human Nature (Hawthorne, N.Y.)|July 17, 2015
Celebrities: From Teachers to Friends : A Test of Two Hypotheses on the Adaptiveness of Celebrity GossipCharlotte J S De Backer, Mark Nelissen, Patrick Vyncke, et al.
The Veterinary Record|October 21, 2017
Future of keeping pet reptiles and amphibians: towards integrating animal welfare, human health and environmental sustainabilityFrank Pasmans, Serge Bogaerts, Johan Braeckman, et al.
BJU International|August 20, 2008
The accuracy of transrectal ultrasonography supplemented with computer-aided ultrasonography for detecting small prostate cancersJohan Braeckman, Philippe Autier, Cristina Soviany, et al.
BJU International|October 10, 2007
Computer-aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancerJohan Braeckman, Philippe Autier, Christian Garbar, et al.
BJU International|November 19, 2011
Detection, localisation and characterisation of prostate cancer by prostate HistoScanning(™)Lucy A M Simmons, Philippe Autier, Frantiŝek Zát'ura, et al.
Drugs - Real World Outcomes|July 12, 2016
Changes in Body Image in Patients with Prostate Cancer over 2 Years of Treatment with a Gonadotropin-Releasing Hormone Analogue (Triptorelin): Results from a Belgian Non-Interventional StudyHans van den Driessche, Pieter Mattelaer, Peter van Oyen, et al.
The Journal of Urology|September 5, 2017
Long-Term Antitumor Activity and Safety of Enzalutamide Monotherapy in Hormone Naïve Prostate Cancer: 3-Year Open Label Followup ResultsBertrand Tombal, Michael Borre, Per Rathenborg, et al.
The Lancet. Oncology|April 18, 2014
Enzalutamide monotherapy in hormone-naive prostate cancer: primary analysis of an open-label, single-arm, phase 2 studyBertrand Tombal, Michael Borre, Per Rathenborg, et al.
European Urology|February 18, 2015
Long-term Efficacy and Safety of Enzalutamide Monotherapy in Hormone-naïve Prostate Cancer: 1- and 2-Year Open-label Follow-up ResultsBertrand Tombal, Michael Borre, Per Rathenborg, et al.
Pageof 3